Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies

Luca Richeldi, Kevin C. Wilson, Ganesh Raghu

Source: Eur Respir J, 52 (3) 1801485; 10.1183/13993003.01485-2018
Journal Issue: September
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Luca Richeldi, Kevin C. Wilson, Ganesh Raghu. Diagnosing idiopathic pulmonary fibrosis in 2018: bridging recommendations made by experts serving different societies. Eur Respir J, 52 (3) 1801485; 10.1183/13993003.01485-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Diagnosis and management of idiopathic pulmonary fibrosis: French practical guidelines
Source: Eur Respir Rev 2014; 23:193-214
Year: 2014



Diagnosis of idiopathic pulmonary fibrosis: from guidelines to clinical practice
Source: Annual Congress 2009 - Clinical aspects of diffuse parenchymal lung disease
Year: 2009

Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation
Source: Eur Respir J, 55 (4) 1901760; 10.1183/13993003.01760-2019
Year: 2020



Idiopathic pulmonary fibrosis: do scientists focus on publishing rather than on clinical relevance?
Source: Eur Respir J, 55 (6) 2000811; 10.1183/13993003.00811-2020
Year: 2020



The 2015 guidelines for idiopathic pulmonary fibrosis: an important chapter in the evolution of the management of patients with IPF
Source: Eur Respir J 2015; 46: 883-886
Year: 2015


Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry
Source: Eur Respir J 2015; 46: 186-196
Year: 2015



Do physicians in primary health care recognize pulmonary fibrosis?
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Idiopathic pulmonary fibrosis trials: recommendations for the jury
Source: Eur Respir J 2011; 38: 1002-1004
Year: 2011


The epidemiologic features and the patterns of medical resource use in idiopathic pulmonary fibrosis (IPF) in Korea
Source: International Congress 2015 – IPF: clinical aspects
Year: 2015


Japanese guideline for the treatment of idiopathic pulmonary fibrosis 2017
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017

Diagnosis, treatment and attitudes about idiopathic pulmonary fibrosis in Latin American physicians
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016

Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016


Current approaches to the diagnosis and treatment of idiopathic pulmonary fibrosis in Europe: the AIR survey
Source: Eur Respir Rev 2014; 23:225-230
Year: 2014



IPF Care, a support program for patients with idiopathic pulmonary fibrosis in the UK
Source: International Congress 2015 – Latest insights into chronic care
Year: 2015


Development of a national patient charter for idiopathic pulmonary fibrosis
Source: International Congress 2016 – IPF clinical
Year: 2016


Selected clinical highlights from the 2012 ERS congress in Vienna
Source: Eur Respir J 2013; 41: 1219-1227
Year: 2013



Imaging of idiopathic pulmonary fibrosis based on case presentations: guidelines, pitfalls and prevention of misdiagnosis
Source: Virtual Congress 2021 – Imaging grand round
Year: 2021


Can current guidelines improve the diagnosis of a usual interstitial pneumonia among general radiologists?
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016


Expectations of patients suffering from idiopathic pulmonary fibrosis about their treatment: results of the French national survey, RESPIR
Source: International Congress 2019 – The changing face of rare diffuse parenchymal lung diseases: recent advances in pathogenesis, clinical manifestations and treatment
Year: 2019


Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models
Source: Eur Respir Rev 2014; 23:231-238
Year: 2014